Core Memory New, More Precise Cancer Therapies Could Soon Be Here - EP 51 Richard Fuisz
34 snips
Jan 12, 2026 
In this captivating discussion, guest host Arne Marrogi interviews Richard Fuisz, a biotech entrepreneur and scientist who founded Nonfiction Labs. They explore groundbreaking techniques using magnetically controllable proteins to enhance cancer therapies, potentially reducing harmful side effects. Richard shares insights on the challenges of DNA synthesis, his family's legacy in invention, and the competitive landscape of biotech between the U.S. and China. They even touch on the role of AI in protein design and the exciting future of therapeutics driven by magnetic technology.
AI Snips
Chapters
Books
Transcript
Episode notes
Hands-On Student Labs Create Biotech Founders
- Early undergrad bio projects at Stanford enabled hands-on biotech experimentation outside traditional paths.
- Richard used a student-funded after-hours lab to build DNA synthesis skills and entrepreneurial experience.
Mission-District DNA Synthesis Startup
- Richard and cofounders built a DNA synthesis startup from a warehouse in San Francisco's Mission district.
- The company struggled with commodity margins and talent shortages during COVID, leading to pivoting away.
Value In Non-Model Organisms
- Non-model organisms often yield unique biological tools that mainstream model systems miss.
- Arcadia focused on weird organisms to find novel proteins and capabilities useful across biology.
